Citation: G. Carles et al., THE EFFECT OF COMBINING ANTITUBULIN AGENTS ON DIFFERENTIATED AND UNDIFFERENTIATED HUMAN COLON-CANCER CELLS, Anti-cancer drugs, 9(3), 1998, pp. 209-221
Authors:
KADI A
PICHARD V
LEHMANN M
BRIAND C
BRAGUER D
MARVALDI J
ROGNONI JB
LUIS J
Citation: A. Kadi et al., EFFECT OF MICROTUBULE DISRUPTION ON CELL-ADHESION AND SPREADING, Biochemical and biophysical research communications, 246(3), 1998, pp. 690-695
Authors:
GUILLET P
LASCOLA B
BAGARRYLIEGEY D
LORVELLEC K
MARTIN N
NICOARA A
BACIUCHKA M
DUFFAUD F
CARISSIMI P
COHEN P
DELORME J
CARLE G
BRAGUER D
QUILICHINI F
CREVAT A
FAVRE R
Citation: P. Guillet et al., CLINICAL PILOT-STUDY ON REPEATED SYSTEMAT ICALLY USE OF HEPARIN, VANCOMYCIN AND COLIMYCIN LOCKED FLUSH SOLUTION FOR CENTRAL INTRAVENOUS TOTALLY IMPLANTED CATHETER IN CANCEROLOGY, Pathologie et biologie, 45(6), 1997, pp. 506-513
Authors:
ELKHYARI S
BOURGAREL V
BARRA Y
BRAGUER D
BRIAND C
Citation: S. Elkhyari et al., PRETREATMENT BY TUBULIN AGENTS DECREASES C-MYC INDUCTION IN HUMAN COLON-CARCINOMA CELL-LINE HT29-D4, Biochemical and biophysical research communications, 231(3), 1997, pp. 751-754
Authors:
BERLAND Y
CARLES G
TABOUY L
CHAUVETMONGES AM
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM COUNTERACTS THE IN-VITRO CYTOTOXICITY OF CELLULOSE-ACETATE EXTRACTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1120-1120
Authors:
BLIN O
AZULAY JP
DESNUELLE C
BILLETURC F
BRAGUER D
BESSE D
BRANGER E
CREVAT A
SERRATRICE G
POUGET JY
Citation: O. Blin et al., A CONTROLLED ONE-YEAR TRIAL OF DEXTROMETHORPHAN IN AMYOTROPHIC-LATERAL-SCLEROSIS, Clinical neuropharmacology, 19(2), 1996, pp. 189-192
Authors:
CARLES G
BRAGUER D
ROGNONI JB
ROCCABIANCA M
MARVALDI J
BRIAND C
Citation: G. Carles et al., MODIFICATION OF THE ACTION OF PACLITAXEL ON A HUMAN DIFFERENTIATED COLON-CANCER CELL-LINE AFTER LONG-TERM PRETREATMENT AT VERY-LOW DOSE, Bulletin du cancer, 83(2), 1996, pp. 135-138
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
GARCIA P
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM IMPROVES IN-VITRO MITOCHONDRIAL BIOCOMPATIBILITY OF HEMODIALYSERS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 482-482
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
GARCIA P
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., DILTIAZEM IMPROVES IN-VITRO MITOCHONDRIAL BIOCOMPATIBILITY OF HEMODIALYSERS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 520-520
Citation: P. Garcia et al., SIMULTANEOUS COMBINATION OF MICROTUBULE DEPOLYMERIZING AND STABILIZING AGENTS ACTS AT LOW-DOSES, Anti-cancer drugs, 6(4), 1995, pp. 533-544
Authors:
BERLAND Y
TABOUY L
CHAUVETMONGES AM
BRAGUER D
BRUNET P
CREVAT A
Citation: Y. Berland et al., MITOCHONDRIA AS AN IN-VITRO TEST OF HEMODIALYSER BIOCOMPATIBILITY, Journal of the American Society of Nephrology, 5(3), 1994, pp. 433-433
Authors:
GARCIA P
BRAGUER D
CARLES G
ELKHYARI S
BARRA Y
DEINES C
BARASOAIN I
BRIAND C
Citation: P. Garcia et al., COMPARATIVE EFFECTS OF TAXOL AND TAXOTERE ON 2 DIFFERENT HUMAN CARCINOMA CELL-LINES, Cancer chemotherapy and pharmacology, 34(4), 1994, pp. 335-343
Authors:
DEBAL V
ALLAM N
MORJANI H
MILLOT JM
BRAGUER D
BREILLOUT F
MANFAIT M
Citation: V. Debal et al., CHARACTERIZATION OF A NAVELBINE-RESISTANT BLADDER-CARCINOMA CELL-LINECROSS-RESISTANT TO TAXOIDS, British Journal of Cancer, 70(6), 1994, pp. 1118-1125
Authors:
ELKHYARI S
BOTTO F
CARLES G
BRAGUER D
BRIAND C
BERTHOIS Y
MARTIN PM
RIVA C
BARRA Y
Citation: S. Elkhyari et al., EXPRESSION OF NUCLEAR ONCOGENES AND MARKERS OF DIFFERENTIATION IN HUMAN MULTIDRUG-RESISTANT HBL100 CELL-LINE, The Cancer journal, 6(5), 1993, pp. 285-290